Academic Radiology
Volume 16, Issue 12 , Pages 1483-1492 , December 2009

Dynamic Evolutionary Changes in Blood Flow Measured by MDCT in a Hepatic VX2 Tumor Implant over an Extended 28-day Growth Period: Time-Density Curve Analysis

  • Hanping Wu, MD, PhD

      Affiliations

    • Department of Radiology, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106
    • ,
  • Agata A. Exner, PhD

      Affiliations

    • Department of Radiology, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106
    • ,
  • Hong Shi, MD

      Affiliations

    • Cardiovascular Research Institute, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106
    • ,
  • Joshua Bear, MA, BS

      Affiliations

    • University Hospitals Case Medical Center, School of Medicine, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106
    • ,
  • John R. Haaga, MD

      Affiliations

    • Department of Radiology, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106
    • Corresponding Author InformationAddress correspondence to: J.R.H.

Received 7 July 2009 ,Accepted 9 September 2009.

References 

  1. Ippolito D, Sironi S, Pozzi M, et al. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol. 2008;15:919–927
  2. Huang JS, Pan HB, Chou CP, et al. Optimizing scanning phases in detecting small (<2 cm) hepatocellular carcinoma: whole-liver dynamic study with multidetector row CT. J Comput Assist Tomogr. 2008;32:341–346
  3. Yu JS, Rofsky NM. Hepatic metastases: perilesional enhancement on dynamic MRI. AJR Am J Roentgenol. 2006;186:1051–1058
  4. Wang JH, Min PQ, Wang PJ, et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol. 2006;186:1423–1430
  5. Tozaki M, Uno S, Kobayashi T, et al. Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRI. Radiat Med. 2004;22:246–253
  6. Murakami T, Kim T, Hori M, Federle MP. Double arterial phase multi-detector row helical CT for detection of hypervascular hepatocellular carcinoma. Radiology. 2003;229:931–932
  7. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology. 2001;218:763–767
  8. Yamashita Y, Ogata I, Urata J, et al. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology. 1997;203:121–125
  9. Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology. 1994;193:49–57
  10. Kanematsu M, Semelka RC, Leonardou P, et al. Angiogenesis in hepatocellular nodules: correlation of MR imaging and vascular endothelial growth factor. J Magn Reson Imaging. 2004;20:426–434
  11. Tsuda M, Majima K, Yamada T, et al. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging. 2001;25:409–415
  12. Zhao JG, Feng GS, Kong XQ, et al. Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model. World J Gastroenterol. 2004;10:1415–1420
  13. Kwak BK, Shim HJ, Park US, et al. Correlation of VEGF with contrast enhancement on dual-phase dynamic helical CT in liver tumors: preliminary study. J Korean Med Sci. 2001;16:83–87
  14. Semelka RC, Hussain SM, Marcos HB, et al. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. Radiology. 2000;215:89–94
  15. Ueda K, Matsui O, Kawamori Y, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology. 1998;206:161–166
  16. Kim S, Kim JH, Han JK, et al. Prediction of optimal injection protocol for tumor detection in contrast-enhanced dynamic hepatic CT using simulation of lesion-to-liver contrast difference. Comput Med Imaging Graph. 2000;24:317–327
  17. Stacker SA, Achen MG. From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy. Lymphat Res Biol. 2008;6:165–172
  18. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8:705–713
  19. Eren F, Celikel C, Gulluoglu B. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53. Pathol Oncol Res. 2004;10:47–51
  20. Li L, Wang L, Zhang W, et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res. 2004;24:1973–1979
  21. Au KK, Liong E, Li JY, et al. Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development. J Cell Biochem. 1997;67:131–135
  22. Stewart EE, Chen X, Hadway J, et al. Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model. Radiology. 2006;239:740–750
  23. Weinberg BD, Blanco E, Lempka SF, et al. Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment. J Biomed Mater Res A. 2007;81:205–213
  24. Park HS, Chung JW, Jae HJ, et al. FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model. Korean J Radiol. 2007;8:216–224
  25. Burgener FA, Violante MR. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit. Invest Radiol. 1979;14:410–414
  26. Tanaka H, Taniguchi H, Mugitani T, et al. Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model. Br J Cancer. 1995;72:650–653
  27. Li J, Dong B, Yu X, Li C. Ultrasonographic portography with low mechanical index gray-scale imaging in hepatic VX2 tumor. Ultrasound Med Biol. 2006;32:641–647
  28. Maruyama H, Matsutani S, Saisho H, et al. Sonographic shift of hypervascular liver tumor on blood pool harmonic images with definity: time-related changes of contrast-enhanced appearance in rabbit VX2 tumor under extra-low acoustic power. Eur J Radiol. 2005;56:60–65
  29. Jiang HJ, Zhang ZR, Shen BZ, et al. Functional CT for assessment of early vascular physiology in liver tumors. Hepatobiliary Pancreat Dis Int. 2008;7:497–502
  30. Morimoto K, Sakaguchi H, Tanaka T, et al. Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer. Cardiovasc Intervent Radiol. 2008;31:981–985
  31. Kuszyk BS, Bluemke DA, Choti MA, et al. 1999 ARRS Executive Council Award. Contrast-enhanced CT of small hypovascular hepatic tumors: effect of lesion enhancement on conspicuity in rabbits. American Roentgen Ray Society. AJR Am J Roentgenol. 2000;174:471–475
  32. Jia HS, Quan XY, Zeng S, Wen ZB. [Dynamic evaluation of rabbit VX2 hepatic carcinoma with CT and MRI]. Di Yi Jun Yi Da Xue Xue Bao. 2002;22:141–144
  33. Kanematsu M, Matsuo M, Yamada Y, et al. Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging. 2003;18:40–48
  34. Itai Y, Irie T. Metastatic liver tumor: circumferential versus wedge-shaped perilesional enhancement and quantitative image and pathologic correlation. Radiology. 2001;219:298–300
  35. Itai Y, Matsui O. Blood flow and liver imaging. Radiology. 1997;202:306–314
  36. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996;200:639–649
  37. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology. 1994;190:49–52
  38. Kanematsu M, Hoshi H, Yamada T, et al. Overestimating the size of hepatic malignancy on helical CT during arterial portography: equilibrium phase CT and pathology. J Comput Assist Tomogr. 1997;21:713–719
  39. Kan Z, Ivancev K, Lunderquist A, et al. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology. 1993;187:621–626
  40. Burgener FA, Hamlin DJ. Contrast enhancement of focal hepatic lesions in CT: effect of size and histology. AJR Am J Roentgenol. 1983;140:297–301
  41. Kapanen MK, Halavaara JT, Hakkinen AM. Assessment of vascular physiology of tumorous livers: comparison of two different methods. Acad Radiol. 2003;10:1021–1029
  42. Stewart EE, Chen X, Hadway J, et al. Hepatic perfusion in a tumor model using DCE-CT: an accuracy and precision study. Phys Med Biol. 2008;53:4249–4267

 H.W. supported in part by Siemens Healthcare and P30043703 (to J.R.H).

PII: S1076-6332(09)00502-9

doi: 10.1016/j.acra.2009.09.009

Academic Radiology
Volume 16, Issue 12 , Pages 1483-1492 , December 2009

Article Tools

* Image Usage & Resolution